Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $49.93 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $27.13 | 1 | $0 (2021) |
| Fisher Scientific Company L.L.C. | $11.97 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $10.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11.97 | 1 | Fisher Scientific Company L.L.C. ($11.97) |
| 2021 | $27.13 | 1 | AstraZeneca Pharmaceuticals LP ($27.13) |
| 2019 | $10.83 | 1 | Merck Sharp & Dohme Corporation ($10.83) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Infectious Disease | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Oncology | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,363 | 6,062 | $756,493 | $161,273 |
| 2022 | 22 | 1,935 | 4,977 | $616,460 | $139,543 |
| 2021 | 24 | 1,964 | 4,104 | $484,435 | $124,902 |
| 2020 | 19 | 2,025 | 3,747 | $415,792 | $121,164 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 363 | 1,332 | $197,038 | $41,180 | 20.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 390 | 1,172 | $204,204 | $35,465 | 17.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 105 | 536 | $30,847 | $12,184 | 39.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 181 | 365 | $39,420 | $7,990 | 20.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 181 | 650 | $32,500 | $6,461 | 19.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 68 | 84 | $24,696 | $5,471 | 22.2% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 29 | 58 | $12,133 | $5,020 | 41.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 129 | 176 | $17,600 | $4,976 | 28.3% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 34 | 53 | $14,516 | $4,743 | 32.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 92 | 146 | $20,537 | $4,708 | 22.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 107 | 206 | $14,060 | $4,507 | 32.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 22 | 118 | $9,569 | $4,018 | 42.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 115 | 347 | $18,218 | $3,455 | 19.0% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 109 | 143 | $30,030 | $2,985 | 9.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 25 | 86 | $12,642 | $2,833 | 22.4% |
| 88364 | Genetic sequencing localization, each additional procedure | Office | 2023 | 31 | 99 | $11,880 | $2,729 | 23.0% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 14 | 14 | $8,596 | $2,063 | 24.0% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 33 | 49 | $9,476 | $1,752 | 18.5% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 20 | 52 | $5,512 | $1,626 | 29.5% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 25 | 27 | $5,670 | $1,340 | 23.6% |
| 88172 | Evaluation of fine needle aspirate | Office | 2023 | 29 | 37 | $7,166 | $1,305 | 18.2% |
| 88365 | Genetic sequencing localization, initial procedure | Office | 2023 | 31 | 33 | $5,280 | $1,155 | 21.9% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 50 | 58 | $7,917 | $1,078 | 13.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 80 | 97 | $10,789 | $956.11 | 8.9% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 54 | 74 | $3,108 | $750.73 | 24.2% |
About Dr. Haig Minassian, MD
Dr. Haig Minassian, MD is a Cytopathology healthcare provider based in Red Bank, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114986940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haig Minassian, MD has received a total of $49.93 in payments from pharmaceutical and medical device companies, with $11.97 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($49.93).
As a Medicare-enrolled provider, Minassian has provided services to 8,287 Medicare beneficiaries, totaling 18,890 services with total Medicare billing of $546,882. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Cytopathology
- Location Red Bank, NJ
- Active Since 03/21/2006
- Last Updated 07/20/2010
- Taxonomy Code 207ZC0500X
- Entity Type Individual
- NPI Number 1114986940
Products in Payments
- TAGRISSO (Drug) $27.13
- Procalcitonin (Device) $11.97
- KEYTRUDA (Biological) $10.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.